Literature DB >> 7596949

Doxorubicin-induced cardiotoxicity.

L Samuel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596949      PMCID: PMC2398096          DOI: 10.1136/pgmj.71.835.318

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  3 in total

1.  Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).

Authors:  J Cummings; S Merry; N Willmott
Journal:  Eur J Cancer Clin Oncol       Date:  1986-04

2.  Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin.

Authors:  S Sriskandan; M E O'Brien; I E Smith; P Collins; M E Gore
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

3.  Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum.

Authors:  J Cummings; R Milstead; D Cunningham; S Kaye
Journal:  Eur J Cancer Clin Oncol       Date:  1986-08
  3 in total
  2 in total

1.  Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells.

Authors:  Xianpu Zhang; Jiaojiao Li; Yongbo Cheng; Jianguang Yi; Xin Liu; Wei Cheng
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

2.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases.

Authors:  Ahmed Abu-Zaid; Ayman Zaki Azzam; Osama AlOmar; Hany Salem; Tarek Amin; Ismail A Al-Badawi
Journal:  Ann Saudi Med       Date:  2014 Mar-Apr       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.